Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Non Operating Income: 2010-2016

Historic Other Non Operating Income for China Pharma Holdings (CPHI) over the last 1 years, with Dec 2016 value amounting to -$3,324.

  • China Pharma Holdings' Other Non Operating Income rose 78.06% to -$3,324 in Q4 2016 from the same period last year, while for Dec 2016 it was $1.6 million, marking a year-over-year decrease of 4.15%. This contributed to the annual value of $343,023 for FY2016, which is 79.09% down from last year.
  • According to the latest figures from Q4 2016, China Pharma Holdings' Other Non Operating Income is -$3,324, which was down 42.97% from -$2,325 recorded in Q3 2016.
  • China Pharma Holdings' 5-year Other Non Operating Income high stood at $1.7 million for Q3 2015, and its period low was -$15,152 during Q4 2015.
  • In the last 3 years, China Pharma Holdings' Other Non Operating Income had a median value of -$1,149 in 2014 and averaged $283,332.
  • The largest annual percentage gain for China Pharma Holdings' Other Non Operating Income in the last 5 years was 2,443.84% (2015), contrasted with its biggest fall of 56,218.52% (2015).
  • Quarterly analysis of 3 years shows China Pharma Holdings' Other Non Operating Income stood at $27 in 2014, then tumbled by 56,218.52% to -$15,152 in 2015, then spiked by 78.06% to -$3,324 in 2016.
  • Its Other Non Operating Income was -$3,324 in Q4 2016, compared to -$2,325 in Q3 2016 and -$15,152 in Q4 2015.